Kshitij Wagh1, Beatrice H Hahn2, Bette Korber1,3. 1. T-6 Theoretical Biology & Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico. 2. Departments of Medicine & Microbiology, University of Pennsylvania, Pennsylvania. 3. New Mexico Consortium, Los Alamos, New Mexico, USA.
Abstract
PURPOSE OF REVIEW: The surface of the HIV-1 Env glycoprotein, the target of neutralizing antibodies, is extensively covered by N-linked glycans that create a glycan shield. Broadly neutralizing antibodies (bNAbs), the primary targets of HIV-1 vaccine design, have to negotiate this glycan shield. Here, we review the barriers and opportunities that the HIV-1 glycan shield presents for vaccine induction of bNAbs. RECENT FINDINGS: Glycan shields can impact the nature of the antibody response and influence the development of neutralization breadth in HIV-1 infections. The architecture of the glycan shield arising from glycan interactions and dynamics have been modeled, and its fine structure, that is, the site-wise glycan heterogeneity, has been determined for some isolates. Although the extent of glycan shielding is conserved, the precise number, location and processing of glycans, however, is strain-dependent. New insights continue to reveal how such differences can impact bNAb activity and development. Novel approaches have exploited the glycan shield for designing immunogens that bind the germline precursors of bNAbs, a critical roadblock for vaccine-induction of bNAbs. SUMMARY: The HIV-1 glycan shield can significantly impact the induction and maturation of bNAbs, and a better understanding of how to manipulate it will improve immunogen design.
PURPOSE OF REVIEW: The surface of the HIV-1 Env glycoprotein, the target of neutralizing antibodies, is extensively covered by N-linked glycans that create a glycan shield. Broadly neutralizing antibodies (bNAbs), the primary targets of HIV-1 vaccine design, have to negotiate this glycan shield. Here, we review the barriers and opportunities that the HIV-1 glycan shield presents for vaccine induction of bNAbs. RECENT FINDINGS: Glycan shields can impact the nature of the antibody response and influence the development of neutralization breadth in HIV-1 infections. The architecture of the glycan shield arising from glycan interactions and dynamics have been modeled, and its fine structure, that is, the site-wise glycan heterogeneity, has been determined for some isolates. Although the extent of glycan shielding is conserved, the precise number, location and processing of glycans, however, is strain-dependent. New insights continue to reveal how such differences can impact bNAb activity and development. Novel approaches have exploited the glycan shield for designing immunogens that bind the germline precursors of bNAbs, a critical roadblock for vaccine-induction of bNAbs. SUMMARY: The HIV-1 glycan shield can significantly impact the induction and maturation of bNAbs, and a better understanding of how to manipulate it will improve immunogen design.
Authors: Feng Gao; Mattia Bonsignori; Hua-Xin Liao; Amit Kumar; Shi-Mao Xia; Xiaozhi Lu; Fangping Cai; Kwan-Ki Hwang; Hongshuo Song; Tongqing Zhou; Rebecca M Lynch; S Munir Alam; M Anthony Moody; Guido Ferrari; Mark Berrong; Garnett Kelsoe; George M Shaw; Beatrice H Hahn; David C Montefiori; Gift Kamanga; Myron S Cohen; Peter Hraber; Peter D Kwong; Bette T Korber; John R Mascola; Thomas B Kepler; Barton F Haynes Journal: Cell Date: 2014-07-24 Impact factor: 41.582
Authors: Tongqing Zhou; Nicole A Doria-Rose; Cheng Cheng; Guillaume B E Stewart-Jones; Gwo-Yu Chuang; Michael Chambers; Aliaksandr Druz; Hui Geng; Krisha McKee; Young Do Kwon; Sijy O'Dell; Mallika Sastry; Stephen D Schmidt; Kai Xu; Lei Chen; Rita E Chen; Mark K Louder; Marie Pancera; Timothy G Wanninger; Baoshan Zhang; Anqi Zheng; S Katie Farney; Kathryn E Foulds; Ivelin S Georgiev; M Gordon Joyce; Thomas Lemmin; Sandeep Narpala; Reda Rawi; Cinque Soto; John-Paul Todd; Chen-Hsiang Shen; Yaroslav Tsybovsky; Yongping Yang; Peng Zhao; Barton F Haynes; Leonidas Stamatatos; Michael Tiemeyer; Lance Wells; Diana G Scorpio; Lawrence Shapiro; Adrian B McDermott; John R Mascola; Peter D Kwong Journal: Cell Rep Date: 2017-04-25 Impact factor: 9.423
Authors: Wen-Han Yu; David Su; Julia Torabi; Christine M Fennessey; Andrea Shiakolas; Rebecca Lynch; Tae-Wook Chun; Nicole Doria-Rose; Galit Alter; Michael S Seaman; Brandon F Keele; Douglas A Lauffenburger; Boris Julg Journal: JCI Insight Date: 2019-09-05
Authors: Jianhui Tian; Cesar A López; Cynthia A Derdeyn; Morris S Jones; Abraham Pinter; Bette Korber; S Gnanakaran Journal: PLoS Comput Biol Date: 2016-10-07 Impact factor: 4.475
Authors: Daniel W Kulp; Jon M Steichen; Matthias Pauthner; Xiaozhen Hu; Torben Schiffner; Alessia Liguori; Christopher A Cottrell; Colin Havenar-Daughton; Gabriel Ozorowski; Erik Georgeson; Oleksandr Kalyuzhniy; Jordan R Willis; Michael Kubitz; Yumiko Adachi; Samantha M Reiss; Mia Shin; Natalia de Val; Andrew B Ward; Shane Crotty; Dennis R Burton; William R Schief Journal: Nat Commun Date: 2017-11-21 Impact factor: 14.919
Authors: Max Medina-Ramírez; Fernando Garces; Amelia Escolano; Patrick Skog; Steven W de Taeye; Ivan Del Moral-Sanchez; Andrew T McGuire; Anila Yasmeen; Anna-Janina Behrens; Gabriel Ozorowski; Tom L G M van den Kerkhof; Natalia T Freund; Pia Dosenovic; Yuanzi Hua; Alexander D Gitlin; Albert Cupo; Patricia van der Woude; Michael Golabek; Kwinten Sliepen; Tanya Blane; Neeltje Kootstra; Mariëlle J van Breemen; Laura K Pritchard; Robyn L Stanfield; Max Crispin; Andrew B Ward; Leonidas Stamatatos; Per Johan Klasse; John P Moore; David Nemazee; Michel C Nussenzweig; Ian A Wilson; Rogier W Sanders Journal: J Exp Med Date: 2017-08-28 Impact factor: 14.307
Authors: Weston B Struwe; Elena Chertova; Joel D Allen; Gemma E Seabright; Yasunori Watanabe; David J Harvey; Max Medina-Ramirez; James D Roser; Rodman Smith; David Westcott; Brandon F Keele; Julian W Bess; Rogier W Sanders; Jeffrey D Lifson; John P Moore; Max Crispin Journal: Cell Rep Date: 2018-08-21 Impact factor: 9.423
Authors: Celia C LaBranche; Rory Henderson; Allen Hsu; Shay Behrens; Xuejun Chen; Tongqing Zhou; Kevin Wiehe; Kevin O Saunders; S Munir Alam; Mattia Bonsignori; Mario J Borgnia; Quentin J Sattentau; Amanda Eaton; Kelli Greene; Hongmei Gao; Hua-Xin Liao; Wilton B Williams; James Peacock; Haili Tang; Lautaro G Perez; Robert J Edwards; Thomas B Kepler; Bette T Korber; Peter D Kwong; John R Mascola; Priyamvada Acharya; Barton F Haynes; David C Montefiori Journal: PLoS Pathog Date: 2019-09-17 Impact factor: 6.823
Authors: Xiaoying Shen; Haili Tang; Charlene McDanal; Kshitij Wagh; Will Fischer; James Theiler; Hyejin Yoon; Dapeng Li; Barton F Haynes; Kevin O Sanders; Sandrasegaram Gnanakaran; Nick Hengartner; Rolando Pajon; Gale Smith; Filip Dubovsky; Gregory M Glenn; Bette Korber; David C Montefiori Journal: bioRxiv Date: 2021-01-29
Authors: Xiaoying Shen; Haili Tang; Charlene McDanal; Kshitij Wagh; William Fischer; James Theiler; Hyejin Yoon; Dapeng Li; Barton F Haynes; Kevin O Sanders; Sandrasegaram Gnanakaran; Nick Hengartner; Rolando Pajon; Gale Smith; Gregory M Glenn; Bette Korber; David C Montefiori Journal: Cell Host Microbe Date: 2021-03-05 Impact factor: 31.316
Authors: Anna Schorcht; Christopher A Cottrell; Pavel Pugach; Rajesh P Ringe; Alvin X Han; Joel D Allen; Tom L G M van den Kerkhof; Gemma E Seabright; Edith E Schermer; Thomas J Ketas; Judith A Burger; Jelle van Schooten; Celia C LaBranche; Gabriel Ozorowski; Natalia de Val; Daniel L V Bader; Hanneke Schuitemaker; Colin A Russell; David C Montefiori; Marit J van Gils; Max Crispin; P J Klasse; Andrew B Ward; John P Moore; Rogier W Sanders Journal: J Virol Date: 2021-10-20 Impact factor: 5.103
Authors: Myungjin Lee; Anita Changela; Jason Gorman; Reda Rawi; Tatsiana Bylund; Cara W Chao; Bob C Lin; Mark K Louder; Adam S Olia; Baoshan Zhang; Nicole A Doria-Rose; Susan Zolla-Pazner; Lawrence Shapiro; Gwo-Yu Chuang; Peter D Kwong Journal: Nat Commun Date: 2021-11-09 Impact factor: 14.919